These findings demonstrate that the ratio of Aurora B to INCENP is critical for full Aurora B activity and that increased expression of Aurora B without concomitant expression of INCENP, as is common in breast cancer, results in reduced rather than elevated levels of Aurora B substrate phosphorylation. Here, AURKB is linked to breast carcinoma.